Prospective non interventional study of cabozantinib tablets in adults with advanced renal cell carcinoma following prior vascular endothelial growth factor (VEGF)-targeted therapy (Cassiope)

15/12/2017
01/03/2024
EU PAS number:
EUPAS19464
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

f-fr-60000-001-protocol

English (4.62 MB - PDF) View document
Study results
Study results

F-FR-60000-001_CSR Abstract_Redacted (002)

English (2.14 MB - PDF) View document
Study report
Study report

F-FR-60000-001_synopsis_06Nov2020

English (185.92 KB - PDF) View document
Other information